Holiday Sale | Save 50%
Holiday Sale | Save 50%
Published

Ottawa, Alberta announce $162M rare disease drug agreement

  • Alberta's agreement with the federal government is worth $162 million to provide access to drugs for rare diseases.
  • Alberta will receive about $54 million annually for three years for drugs, diagnostics, and screening.
  • This agreement aims to ensure access to medication and support for Albertans with rare diseases, according to Health Minister Mark Holland.
Insights by Ground AI
Does this summary seem wrong?
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 63% of the sources lean Left
63% Left
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)